Moleculin Biotech MBRX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 2.29 | 15 | -85.1 | -13 | -56.48 | 23 |
| 2025Q4 | 3.31 | 15 | 16 | 73.22 | 22 | |
| 2025Q3 | 13.25 | -27 | -35 | -167.05 | 20 | |
| 2025Q2 | 7.55 | -7 | -8 | -35.86 | 22 | |
| 2025Q1 | 24.34 | 0 | -104.96 | -6 | -31.12 | 21 |
| 2024Q4 | 42.5 | 11 | -24.61 | -2 | -11.4 | 17 |
| 2024Q3 | 71 | 7 | -84.12 | -11 | -43.26 | 23 |
| 2024Q2 | 88 | 18 | -21.98 | -4 | -15.31 | 26 |
| 2024Q1 | 147.75 | 22 | -20.86 | -5 | -14.39 | 31 |
| 2023Q4 | 321.9 | 26 | -33.55 | -10 | -26.42 | 38 |
| 2023Q3 | 160.31 | 35 | -14.88 | -6 | -12.95 | 40 |
| 2023Q2 | 217.05 | 40 | -13.91 | -6 | -12.17 | 47 |
| 2023Q1 | 360 | 46 | -16.17 | -8 | -14.59 | 51 |
| 2022Q4 | 397.5 | 52 | -12.24 | -7 | -11.03 | 57 |
| 2022Q3 | 397.5 | 58 | -13.8 | -9 | -12.42 | 65 |
| 2022Q2 | 543.75 | 66 | -9.75 | -7 | -8.91 | 73 |
| 2022Q1 | 667.5 | 73 | -9.06 | -7 | -8.43 | 79 |
| 2021Q4 | 697.5 | 79 | -3.53 | -3 | -3.27 | 84 |
| 2021Q3 | 1125 | 81 | -5.28 | -4 | -4.81 | 89 |
| 2021Q2 | 1376.25 | 85 | -4.9 | -4 | -4.39 | 94 |